EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Incidence of Respiratory Syncytial Virus-Associated Hospitalization Among Adults in Ontario, Canada, 2017–2019

Sarah A Buchan iD, Jenna Alessandrini, Samantha S M Drover iD, Melissa K Andrew, Susan E Bronskill iD, Kevin A Brown, Nick Daneman, Shelley L Deeks, Jonathan B Gubbay, Jennie Johnstone iD, Timothy M Karnauchow, Samantha Lee iD und 8 weitere

The Journal of Infectious Diseases · 14.11.2025 · 232 (5) · e799-e810

DOI: 10.1093/infdis/jiaf343 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 30.07.2025. Verfasst von Sarah A Buchan und 19 weiteren Autor:innen. Beteiligte Einrichtung: Communicable Disease Control, Public Health Ontario, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Hospitalization. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR, Institute for Clinical Evaluative Sciences, Ontario Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Respiratory syncytial virus (RSV) causes substantial morbidity and mortality among adults. Given recent RSV vaccine authorizations, data on groups at highest risk are needed to support vaccine program decision making.

Methods

We identified adults aged ≥ 18 years hospitalized with laboratory-confirmed RSV and hospitalizations with RSV-related diagnostic codes in Ontario, Canada (2017–2019). We calculated incidence of hospitalization with 95% confidence intervals (CIs) using Poisson regression stratified by demographic and clinical risk factors, and substratified by age. We reported secondary outcomes including the proportion of individuals with fatal outcomes.

Results

Over 2 respiratory virus seasons, we identified 3928 RSV-associated hospitalizations. Incidence increased steadily with age from 2.0 (95% CI, 1.8–2.3) per 100 000 for those aged 18–49 years to 43.7 (95% CI, 41.0–46.6) per 100 000 for those aged 70–79 years, with a sharp increase to 134.7 (95% CI, 128.6–141.1) per 100 000 for those aged ≥ 80 years. Incidence was higher for those with comorbidities, including chronic kidney disease (receiving dialysis) (494.7; 95% CI, 410.7–595.8) and transplant recipients (370.9; 95% CI, 318.0–432.6), as well as for those living in lower (22.4; 95% CI, 21.1–23.7) versus higher-income neighborhoods (11.8; 95% CI, 10.8–12.8). Among those hospitalized, 10.3% (n = 403) died within 30 days of admission, and 93.1% of deaths occurred in those aged ≥ 60 years. Of survivors, 44.6% of community-dwelling adults aged ≥ 60 years had functional decline requiring formal supports at discharge.

Discussion

We found a substantial burden of RSV among older adults, particularly among those with preexisting medical conditions and those of lower socioeconomic status. These results will inform equitable vaccine recommendations for adults.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Syncytial Virus InfectionsHospitalizationHumansAdultMiddle AgedOntarioAgedIncidenceMaleFemaleAdolescentYoung AdultAged, 80 and overRespiratory Syncytial Virus, HumanRisk FactorsAge Factors

Stichwörter der Autor:innen

RSVadministrative dataadulthospitalizationrisk factors

Autor:innen und Institutionen

  • Communicable Disease Control, Public Health Ontario, Toronto, Ontario, Canada.
  • Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, Ontario, Canada.
  • Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
  • Research and Analytics, ICES, Toronto, Ontario, Canada.
  • Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada.
  • Department of Medicine (Geriatrics), Dalhousie University, Halifax, Nova Scotia, Canada.

ORCID-Profile: Sarah A Buchan, Samantha S M Drover, Susan E Bronskill, Jennie Johnstone, Samantha Lee, Samira Mubareka, Marek Smieja, Jeffrey C Kwong

Förderung

  • CIHR
  • Institute for Clinical Evaluative Sciences
  • Ontario Ministry of Health
  • Ministry of Long-Term Care
  • Canadian Institutes of Health Research

Zitieren

APA

Buchan, S. A., Alessandrini, J., Drover, S. S. M., Andrew, M. K., Bronskill, S. E., Brown, K. A., Daneman, N., Deeks, S. L., Gubbay, J. B., Johnstone, J., Karnauchow, T. M., Lee, S., McGeer, A. J., McNally, J. D., McNeil, S. A., Mubareka, S., Murti, M., Smieja, M., Wilson, S. E., & Kwong, J. C. (2025). Incidence of Respiratory Syncytial Virus-Associated Hospitalization Among Adults in Ontario, Canada, 2017–2019. The Journal of Infectious Diseases, 232(5), e799-e810. https://doi.org/10.1093/infdis/jiaf343

Vancouver

Buchan SA, Alessandrini J, Drover SSM, Andrew MK, Bronskill SE, Brown KA, et al. Incidence of Respiratory Syncytial Virus-Associated Hospitalization Among Adults in Ontario, Canada, 2017–2019. The Journal of Infectious Diseases. 2025;232(5):e799-e810. doi:10.1093/infdis/jiaf343

BibTeX
@article{Buchan2025,
  author = {Buchan, Sarah A and Alessandrini, Jenna and Drover, Samantha S M and Andrew, Melissa K and Bronskill, Susan E and Brown, Kevin A and Daneman, Nick and Deeks, Shelley L and Gubbay, Jonathan B and Johnstone, Jennie and Karnauchow, Timothy M and Lee, Samantha and McGeer, Allison J and McNally, J Dayre and McNeil, Shelly A and Mubareka, Samira and Murti, Michelle and Smieja, Marek and Wilson, Sarah E and Kwong, Jeffrey C},
  title = {Incidence of Respiratory Syncytial Virus-Associated Hospitalization Among Adults in Ontario, Canada, 2017–2019},
  journal = {The Journal of Infectious Diseases},
  year = {2025},
  volume = {232},
  number = {5},
  pages = {e799--e810},
  doi = {10.1093/infdis/jiaf343}
}
Kostenlos starten →